AIDOT's Booth in MEDIKA 2022
[View original text]
Accelerating overseas expansion through meetings with 80 companies
On 25th of November, AIDOT (CEO Jae-hoon Jeong), a company specializing in medical artificial intelligence (AI) solutions, participated in 'MEDIKA 2022 (hereafter referred to as
Medika)' held in Dusseldorf, Germany from 14th~17th of November and received a great response by introducing unrivaled medical AI technology.
Medika is one of the world's top three medical device exhibitions, and approximately 5,000 companies from 150 countries, 150,000 people, and in Cosmoprof exhibition halls, there
are more than 1,300 companies and 40,000 people from 45 countries attended.
At this exhibition, AIDOT presented 5 artificial intelligence solutions that are currently in the commercialization preparation and development stage along with its representative
product, the cervical cancer screening system 'Cerviray AI' △Alcoholic Liver Disease Early Diagnosis Solution 'BIO dot AI'. △'SONO dot AI', a carotid artery diagnosis system for prevention
of stroke, △'GIGA dot AI', a real-time gastrointestinal endoscopy examination system, with those five sustems, AIDOT succssfully held meetings with about 80 companies around the
world during this exhibition.
In particular, Cerviray derived very high level of interest from visitors, so the brochures prepared before the booth were exhausted, and samples of the device were purchased on site.
AIDOT's global sales marketing PIC said, “AIDOT was the only company that demonstrated AI in front of the visitors among artificial intelligence companies participating in Medika, and I was very happy to be able to showcase its excellent technology. In particular, in the case of Cerviray, we signed a contract with 'L' company in Vietnam at this exhibition, and achieved the result of securing potential customers for other solutions besides Cerviray.” Also he said, “As we have held meetings with several buyers, we will do our best to generate
substantial global sales by focusing on overseas sales and marketing.”
Overview of AIDOT Inc.
Since its foundation in June 2014, AIDOT has been recognized for its technological prowess, including being selected for KIC China and various government projects. In addition, an
artificial intelligence-based reading system combining carotid ultrasound and genomic information was jointly developed with Hallym University Chuncheon Sacred Heart Hospital's
Department of Neurosurgery, and a digestive AI diagnosis system that integrated gastroscopy, capsule endoscopy, and colonoscopy was also completed.
Korea News Association / 25th. Nov. 2022